Brock Pluimer

Brock Pluimer

Auto-generated profile, based on publicly available information

Brock Pluimer

Susan Samueli Integrative Health Institute, University of California Irvine , Irvine, CA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2023 in Science Robotics
Verified
Journal Article
Closed access
LCLeonardo Christov-Moore
Leonardo Christov-Moore
Nicco ReggenteNicco Reggente
Nicco Reggente
AVAnthony Vaccaro
Anthony Vaccaro
FSFelix Schoeller
Felix Schoeller
BPBrock Pluimer
Brock Pluimer
JKJonas T. Kaplan
Jonas T. Kaplan
Given the accelerating powers of artificial intelligence (AI), we must equip artificial agents and robots with empathy to prevent harmful and irreversible decisions. Current approaches to artificial empathy focus on its cognitive or performative processes, overlooking affect, and thus promote sociopathic behaviors. Artificially vulnerable, fully empathic AI is necessary to prevent sociopathic robots and protect human welfare.

23 November 2022 in Science Advances
Verified
Journal Article
Open access
YGYijie Geng
Yijie Geng
TZTejia Zhang
Tejia Zhang
IAIvy G. Alonzo
Ivy G. Alonzo
SGSean C. Godar
Sean C. Godar
CYChristopher Yates
Christopher Yates
RPRandall T. Peterson
Randall T. Peterson
Little is understood about the embryonic development of sociality. We screened 1120 known drugs and found that embryonic inhibition of topoisomerase IIα (Top2a) resulted in lasting social deficits in zebrafish. In mice, prenatal Top2 inhibition caused defects in social interaction and communication, which are behaviors that relate to core symptoms of autism. Mutation of Top2a in zebrafish caused down-regulation of a set of genes highly enriched for genes associated with autism in humans. Both the Top2a-regulated and autism-associated gene sets have binding sites for polycomb repressive complex 2 (PRC2), a regulatory complex responsible for H3K27 trimethylation (H3K27me3). Moreover, both gene sets are highly enriched for H3K27me3. Inhibition of the PRC2 component Ezh2 rescued social deficits caused by Top2 inhibition. Therefore, Top2a is a key component of an evolutionarily conserved pathway that promotes the development of social behavior through PRC2 and H3K27me3.

2 April 2026 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Open access
DNDing Quan Ng
Ding Quan Ng
MHMatthew Heshmatipour
Matthew Heshmatipour
JTJulia Trudeau
Julia Trudeau
ASApeksha Sridhar
Apeksha Sridhar
BPBrock Pluimer
Brock Pluimer
ACAlexandre Chan
Alexandre Chan
Background: We conducted a randomized, double-blinded pilot trial to compare the impact of two electroacupuncture (EA) regimens on co-occurring neuropsychiatric symptoms among breast cancer survivors (BCS). Methods: BCS who self-reported cognitive impairment, fatigue, insomnia, or psychological distress were randomized (1:1) to receive ten weekly EA to target either neuropsychiatric-specific (nEA) or non-neuropsychiatric-specific (sEA) acupoints. Primary endpoints were the within-group pre-post effect sizes (Glass’s Δ) in symptom severities, adjusted for multiple comparisons (p-adjusted). Outcomes were assessed using neurocognitive tests (CANTAB®), PROs (FACT-Cog, MFSI-SF, EORTC QLQ-C30), plasma biomarkers, and neuroimaging. Responders were defined by reliable change index (for objective cognition) or MCID (for PROs). Results: Thirty-five were recruited, with 30 (86%) completing all sessions. The mean (±SD) age was 58.2 (±12.2) years, and 86% reported co-occurring symptoms. Following treatment, the nEA group demonstrated significant improvements in attention (T3: Δ = 0.562, T4: Δ = 0.708, both p-adjusted < 0.05) and distress (T3: Δ = 0.764, T4: Δ = 0.711, both p-adjusted < 0.05). More responders were observed after nEA treatment for objective cognition (42.9% vs 12.5%) and distress (50% vs 37.5%). nEA-treated participants showed increased gray matter volume compared to sEA (p = 0.033), which positively correlated with better attention function (r = 0.69, p = 0.020). nEA-related improvements in memory and response speed were associated with reduced connectivity in the Default Mode Network (DMN–SFG, r=-0.93, p < 0.01) and increased connectivity in the Dorsal Attention Network (DAN–SMG, r = 0.86, p < 0.001), respectively. All adverse events were grade 2 or lower. Conclusions: EA targeting neuropsychiatric-specific acupoints suggests improvements in cognition and distress symptoms in BCS, warranting validation in larger, multicenter trials. Clinicaltrials.gov: NCT05283577.

24 January 2026 in Neuroscience Informatics
Verified
Journal Article
Open access
BPBrock Pluimer
Brock Pluimer
ASApeksha Sridhar
Apeksha Sridhar
IMIshtiaq Mawla
Ishtiaq Mawla
HWHelen Mengxuan Wu
Helen Mengxuan Wu
RLRoshni Lulla
Roshni Lulla
RHRichard Harris
Richard Harris